M.D., M.B.A, SVP Medical Affairs, Chief Medical Officer, Medigene AG
Kai Pinkernell is SVP Medical Affairs, CMO, at Medigene AG, a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried, Germany. He is responsible for clinical-, regulatory affairs and GMP process development. Previously, Dr. Pinkernell held leadership positions with Miltenyi Biotec GmbH and Cytori Therapeutics Inc in basic and clinical research as well as sales and marketing. He received training and worked at the German Heart Center/Klinikum Rechts der Isar, in Munich, Germany and at Tulane University, New Orleans, USA. Dr. Pinkernell received his medical degree from the WWU in Muenster, Germany, and a Master of Business Administration from the Marshall School of Business at USC, Los Angeles, USA.
Presentation Title and Company Description
Immunotherapy Showcase: Using Cutting-edge Technologies to Develop TCR-based Immunotherapies
Medigene AG, a public listed biotechnology company, concentrates on the development of personalized T cell-based immunotherapies. The company is developing highly innovative, complementary treatment platforms to target various types and stages of cancer with candidates in clinical and preclinical development.